Buchumschlag

Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke

Non-vitamin K antagonist oral anticoagulants (NOACs) have gained increasing importance for stroke prevention in patients with non-valvular atrial fibrillation (AF). With changing prescription practice, among other factors, clinicians can expect to see rising numbers of patients with ischemic stroke...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoyer, Carolin (VerfasserIn) , Filipov, Alexandra (VerfasserIn) , Neumaier-Probst, Eva (VerfasserIn) , Szabo, Kristina (VerfasserIn) , Ebert, Anne (VerfasserIn) , Alonso, Angelika (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 February 2018
In: Journal of thrombosis and thrombolysis
Year: 2018, Jahrgang: 45, Heft: 4, Pages: 529-535
ISSN:1573-742X
DOI:10.1007/s11239-018-1634-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11239-018-1634-1
Volltext
Verfasserangaben:Carolin Hoyer, Alexandra Filipov, Eva Neumaier-Probst, Kristina Szabo, Anne Ebert, Angelika Alonso
Beschreibung
Zusammenfassung:Non-vitamin K antagonist oral anticoagulants (NOACs) have gained increasing importance for stroke prevention in patients with non-valvular atrial fibrillation (AF). With changing prescription practice, among other factors, clinicians can expect to see rising numbers of patients with ischemic stroke and pre-existing NOAC therapy. Few data exist regarding a potential impact of NOAC on stroke severity and outcome.
Beschreibung:Gesehen am 07.09.2020
Beschreibung:Online Resource
ISSN:1573-742X
DOI:10.1007/s11239-018-1634-1

Ähnliche Einträge